Cargando…
Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
BACKGROUND: Formation of advanced glycation endproducts (AGEs), endothelial dysfunction, and low-grade inflammation are intermediate pathways of hyperglycemia-induced vascular complications. We investigated the effect of benfotiamine on markers of these pathways in patients with type 2 diabetes and...
Autores principales: | Alkhalaf, Alaa, Kleefstra, Nanne, Groenier, Klaas H., Bilo, Henk J. G., Gans, Reinold O. B., Heeringa, Peter, Scheijen, Jean L., Schalkwijk, Casper G., Navis, Gerjan J., Bakker, Stephan J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391239/ https://www.ncbi.nlm.nih.gov/pubmed/22792314 http://dx.doi.org/10.1371/journal.pone.0040427 |
Ejemplares similares
-
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010) -
Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010) -
Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009) -
Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)
por: Riphagen, Ineke J., et al.
Publicado: (2015) -
Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)
por: Gerrits, Esther G., et al.
Publicado: (2014)